INBX SCHEDULE 13G/A: SEC filing
Viking Global Investors and affiliated entities
Filed with the SEC on · accession 0000905148-26-003736
INBX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. Viking Global Investors and affiliated entities filed a joint filing agreement as an amendment to their Schedule 13G regarding their position in Inhibrx Biosciences. The stock moved -8.9% by the first close after the filing.
Summary of the filing
Viking Global Investors and affiliated entities filed a joint filing agreement as an amendment to their Schedule 13G regarding their position in Inhibrx Biosciences. The filing is a procedural exhibit and does not disclose any change in ownership or intent.
Key details
How INBX stock reacted
Close before
$97.01
Aug 13, 2026
First close after
-8.91%
$88.37
5 trading days
+2.21%
$99.15
Since filing
-12.87%
$84.52
✦ Ask GOAX AI about this filing — what it means for INBX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INBX?
Click hereFrequently asked questions
What did INBX file with the SEC on Aug 14, 2026?
INBX filed a SCHEDULE 13G/A (SEC filing). Viking Global Investors and affiliated entities filed a joint filing agreement as an amendment to their Schedule 13G regarding their position in Inhibrx Biosciences. The filing is a procedural exhibit and does not disclose any change in ownership or intent.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did INBX stock react to this filing?
INBX closed at $97.01 before the filing and $88.37 on Aug 14, 2026 (-8.91%). Five trading days later: $99.15 (+2.21%).
Other INBX SEC filings
- SCHEDULE 13G/A · SEC filingOct 28, 2026
- 8-K · SEC filingSep 28, 2026
- 8-K · Fda approvalSep 8, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G · SEC filingAug 14, 2026
- 8-K · SEC filingAug 13, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · Material agreementJul 16, 2026
- 8-K · Fda approvalJun 15, 2026
- 8-K · Board changeJun 3, 2026
Get alerts when INBX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days